_1571651253328.png?format=webp&height=120&width=120){kind=logo}
SINOMED - About the company
SINOMED is a funded company based in Tianjin (China), founded in 2007 by Jianhua Sun. It operates as a Provider of coronary stent and interventional devices. The company has 126 active competitors, including 45 funded and 28 that have exited. Its top competitors include companies like TISSIUM, Vivasure Medical and Laminate Medical.
Company Details
Sinomed is developing and providing coronary stent and interventional devices. Its products included SUN, Sleek, and BuMATM. It uses the patented technology of the balloon production line that helps in developing drug-coated coronary stent and the interventional devices.
- Website
- www.sinomed.com/
- Email ID
- *****@sinomedical.net
- Phone Number
- +86 **********
Key Metrics
Founded Year
2007
Location
Tianjin, China
Stage
Funding Raised
Investors
Ranked
11th among 126 active competitors
Employee Count
121 as on Sep 30, 2026
Sign up to download SINOMED's company profile
SINOMED's funding and investors
SINOMED is a funded company. SINOMED has 7 institutional investors.
View details of SINOMED's funding rounds and investors
SINOMED's founders and board of directors
Founder? Claim ProfileThe founders of SINOMED is Jianhua Sun. Jianhua Sun is the CEO of SINOMED.
Here are the details of SINOMED's key team members:
- Jianhua Sun: Founder & CEO of SINOMED.
View details of SINOMED's Founder profiles and Board Members
SINOMED's employee count trend
SINOMED has 121 employees as of Sep 26. Here is SINOMED's employee count trend over the years:
Uncover SINOMED's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
SINOMED's Competitors and alternates
Top competitors of SINOMED include TISSIUM, Vivasure Medical and Laminate Medical. Here is the list of Top 10 competitors of SINOMED, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Developer of vascular sealant for open vascular surgery | $190M | 66/100 | ||
2nd |  Vivasure Medical 2009, Galway (Ireland), Acquired | Developer of polymer implants and delivery systems | $92.1M | 61/100 | |
3rd | Laminate Medical 2012, Rehovot (Israel), Series C | Device to prevent AV Fistula failure by promoting their maturation and patency | $20M | 52/100 | |
4th | EKOS Corporation 1995, Bothell (United States), Acquired | Developer of a device for thrombolysis to treat pulmonary embolism | $58.8M | 52/100 | |
5th | ivWatch 2010, Williamsburg (United States), Series E | Detecting Intravenous infiltration | $90.1M | 51/100 | |
6th | AccessClosure 2002, Mountain View (United States), Acquired | Vascular closure device | $18.7M | 50/100 | |
7th | Access Vascular 2015, Bedford (United States), Series C | Developer of hydrogel-based devices to improve venous access | $54.3M | 50/100 | |
8th | Semprus BioSciences 2006, Cambridge (United States), Acquired | Provider of bio-functional medical surfaces to interface between the body and implantable devices | $26M | 50/100 | |
9th | Cardival Medical 2002, Santa Clara (United States), Acquired | Developer of a device for vascular access management | $169M | 49/100 | |
10th |  Vantis Vascular 2022, San Jose (United States), Series C | Provider of a medical device for vascular interventions | $30M | 48/100 | |
11th | Provider of coronary stent and interventional devices | - | 47/100 |
_1571651253328.png?devicePixelRatio=2&height=30&width=30){kind=logo}
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on SINOMED's competitors? Click here to see the top ones
SINOMED's Investments and acquisitions
SINOMED has made no investments or acquisitions yet.
Reports related to SINOMED
Here is the latest report on SINOMED's sector:
News related to SINOMED
Filter this listMedia has covered SINOMED for 1 event in last 1 year, It was about company updates.
•
•
Sino Medical expects revenue to increase by more than 32% and net profit to soar by 125% in the first half of the yearPencilNews•Jul 30, 2024•SINOMED
•
MicroPort Medical faces huge financial pressure, but its subsidiary Sino-Medical is still looking for acquisitionsJiemian News•Jul 02, 2024•SINOMED
•
•
Sino Medical: Subsidiary products obtained domestic medical device registration certificate36Kr•Mar 07, 2023•SINOMED
•
•
SINOMED Announces First Commercial Implantation and European Launch of HT Supreme Drug-Eluting StentPR Newswire•Aug 18, 2021•SINOMED, NUI Galway
•
•
SINOMED announces the HT Supreme DES has similar performance as the market-leader across the spectrum of lesion complexityPR Newswire•May 27, 2021•SINOMED
•
EEM Supreme HT ™ Healing-Targeted Last Minute Study Results Demonstrated Equivalent Results With Exceptional SafetyPR Newswire•Nov 17, 2020•SINOMED
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about SINOMED
Explore our recently published companies
- Nirmal Water - India based, 2014 founded, Unfunded company
- Uss-2030 - Austria based, Unfunded company
- Western States Contracting - North Las Vegas based, 1980 founded, Unfunded company
- GigaConcept - France based, Unfunded company
- ANDATA - Austria based, Unfunded company
- Space-Core - Japan based, Unfunded company
